CN104825480A - 在简易精神状态检查值为24-26的受试者中改善记忆 - Google Patents

在简易精神状态检查值为24-26的受试者中改善记忆 Download PDF

Info

Publication number
CN104825480A
CN104825480A CN201510144913.5A CN201510144913A CN104825480A CN 104825480 A CN104825480 A CN 104825480A CN 201510144913 A CN201510144913 A CN 201510144913A CN 104825480 A CN104825480 A CN 104825480A
Authority
CN
China
Prior art keywords
vitamin
purposes
compositions
subjects
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510144913.5A
Other languages
English (en)
Chinese (zh)
Inventor
P·J·G·H·坎普伊斯
M·格罗南迪克
A·邦格尔斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41580940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN104825480(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/NL2007/050307 external-priority patent/WO2009002146A1/en
Priority claimed from PCT/NL2007/050306 external-priority patent/WO2009002145A1/en
Priority claimed from PCT/NL2007/050310 external-priority patent/WO2009002148A1/en
Priority claimed from PCT/NL2008/050124 external-priority patent/WO2009082203A1/en
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of CN104825480A publication Critical patent/CN104825480A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201510144913.5A 2007-06-26 2008-06-20 在简易精神状态检查值为24-26的受试者中改善记忆 Pending CN104825480A (zh)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
NLPCT/NL2007/050306 2007-06-26
PCT/NL2007/050307 WO2009002146A1 (en) 2007-06-26 2007-06-26 Supporting activities of daily living
NLPCT/NL2007/050307 2007-06-26
PCT/NL2007/050306 WO2009002145A1 (en) 2007-06-26 2007-06-26 Lipid composition for improving function of brain functioning
NLPCT/NL2007/050310 2007-06-27
PCT/NL2007/050310 WO2009002148A1 (en) 2007-06-27 2007-06-27 Food composition for prodromal dementia patients
EP07123811.7 2007-12-20
EP07123811 2007-12-20
NLPCT/NL2008/050124 2008-03-04
PCT/NL2008/050124 WO2009082203A1 (en) 2007-12-20 2008-03-04 Liquid nucleotides/nucleosides-containing product
CN200880100603A CN101765427A (zh) 2007-06-26 2008-06-20 在简易精神状态检查值为24-26的受试者中改善记忆

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN200880100603A Division CN101765427A (zh) 2007-06-26 2008-06-20 在简易精神状态检查值为24-26的受试者中改善记忆

Publications (1)

Publication Number Publication Date
CN104825480A true CN104825480A (zh) 2015-08-12

Family

ID=41580940

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201510144913.5A Pending CN104825480A (zh) 2007-06-26 2008-06-20 在简易精神状态检查值为24-26的受试者中改善记忆
CN200880100603A Pending CN101765427A (zh) 2007-06-26 2008-06-20 在简易精神状态检查值为24-26的受试者中改善记忆

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN200880100603A Pending CN101765427A (zh) 2007-06-26 2008-06-20 在简易精神状态检查值为24-26的受试者中改善记忆

Country Status (15)

Country Link
US (3) US20100331258A1 (cg-RX-API-DMAC7.html)
EP (2) EP2689782B1 (cg-RX-API-DMAC7.html)
JP (2) JP5841723B2 (cg-RX-API-DMAC7.html)
CN (2) CN104825480A (cg-RX-API-DMAC7.html)
AU (1) AU2008269728B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0813770B1 (cg-RX-API-DMAC7.html)
CA (1) CA2692309C (cg-RX-API-DMAC7.html)
DK (1) DK2170316T3 (cg-RX-API-DMAC7.html)
ES (2) ES2445401T3 (cg-RX-API-DMAC7.html)
MX (1) MX2010000224A (cg-RX-API-DMAC7.html)
NZ (2) NZ599748A (cg-RX-API-DMAC7.html)
PL (1) PL2170316T3 (cg-RX-API-DMAC7.html)
PT (1) PT2170316E (cg-RX-API-DMAC7.html)
RU (2) RU2529815C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009002166A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109310662A (zh) * 2016-04-18 2019-02-05 N·V·努特里奇亚 用于减少生命早期应激诱导的认知下降/神经发生减少的亚油酸和α-亚麻酸

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009002148A1 (en) * 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
CN104825480A (zh) 2007-06-26 2015-08-12 N·V·努特里奇亚 在简易精神状态检查值为24-26的受试者中改善记忆
CN101951923B (zh) 2007-12-20 2013-10-30 N.V.努特里奇亚 含核苷酸/核苷的液态产品
ES2538812T3 (es) * 2008-02-01 2015-06-24 Blackberry Limited Sistema y método para la sincronización de temporización de enlace ascendente junto con la recepción discontinua
WO2011121150A1 (es) * 2010-03-31 2011-10-06 Vegenat, S.A. Producto alimenticio enteral u oral especialmente destinado para la nutrición, prevención y mejora de alteraciones neurológicas, neurodegenerativas o trastornos cognitivos
WO2012091542A1 (en) 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
WO2013066153A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Composition for improving neuropsychological test battery score
WO2013066151A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Improving recognition
WO2013066152A1 (en) 2011-10-31 2013-05-10 N.V. Nutricia Method for improving executive function
CN104136024A (zh) * 2011-10-31 2014-11-05 N·V·努特里奇亚 用于改善神经心理成套测验得分的组合物
CN104144691A (zh) * 2012-03-02 2014-11-12 N·V·努特里奇亚 改善功能突触连通性的方法
WO2014171813A1 (en) * 2013-04-17 2014-10-23 N.V. Nutricia Nutritional composition for improving brain function in phenylketonuria
WO2015115886A1 (en) * 2014-01-31 2015-08-06 N.V. Nutricia Method for treating, stabilizing or slowing down brain glucose metabolism deficit
WO2015115885A1 (en) 2014-01-31 2015-08-06 N.V. Nutricia Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly
WO2017069613A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
CN108567792A (zh) * 2017-03-07 2018-09-25 上海泽生科技开发股份有限公司 一种治疗阿尔茨海默病的复合维生素组合物
BR112019017949A2 (pt) * 2017-04-11 2020-05-19 Nestle Sa níveis de ácidos graxos ômega-3 e vitamina d para identificar e atenuar o envelhecimento cognitivo em indivíduos
JPWO2022244727A1 (cg-RX-API-DMAC7.html) * 2021-05-17 2022-11-24
AU2022345465A1 (en) 2021-09-17 2024-03-21 N.V. Nutricia Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases
US11883457B1 (en) * 2022-09-06 2024-01-30 Optigenex Inc. Method of enhancing cognition in individuals with at least normal cognition

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600197A (en) * 1968-08-27 1971-08-17 Merck & Co Inc Flavor enhancing compositions for foods and beverages
AU4595985A (en) 1984-08-10 1986-02-13 Sentrachem Limited Cancer treatment
JP2525624B2 (ja) 1987-09-21 1996-08-21 雪印乳業株式会社 多価不飽和脂肪酸配合育児用粉乳
US5470838A (en) 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
JPH06237734A (ja) 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd 機能後退性疾患用食品組成物
JPH0717855A (ja) 1992-09-02 1995-01-20 Maruha Corp 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤、痴呆治療剤、または脳機能改善効果を有する機能性食品
US5378488A (en) * 1993-06-10 1995-01-03 Abbott Laboratories Aseptic processing of infant formula
JP3576318B2 (ja) 1996-06-19 2004-10-13 明治乳業株式会社 核酸関連物質含有栄養組成物
JPH10136937A (ja) 1996-11-08 1998-05-26 Takashi Morita 脳細胞機能向上、血管細胞強化、身体各細胞機能向上栄養総合食品
DK0843972T3 (da) * 1996-11-20 2002-12-02 Nutricia Nv Næringsmiddelsammensætning, der indeholder fedtstoffer til behandling af stofskiftesygdomme
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
JP3731983B2 (ja) * 1997-08-27 2006-01-05 明治製菓株式会社 痴呆犬の夜鳴き改善薬
US20070004670A1 (en) * 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
US8518882B2 (en) * 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
FR2787799B1 (fr) * 1998-12-23 2001-03-09 Rhodia Chimie Sa Composition comprenant une ecorce inorganique et un noyau comportant au moins un compose polyhydroxyle
GB9916536D0 (en) * 1999-07-14 1999-09-15 Scarista Limited Nutritional or pharmaceutical compositions
EP1090636A1 (en) 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
GB9925709D0 (en) 1999-10-30 1999-12-29 Smithkline Beecham Plc Composition
ES2323940T3 (es) 2000-05-01 2009-07-28 Accera, Inc. Uso de trigliceridos de cadena media para el tratamiento y prevencion de la enfermedad de alzheimer.
US6835750B1 (en) * 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
CA2594883A1 (en) 2001-04-30 2002-11-07 Trommsdorff Gmbh & Co. Kg Arzneimittel Pharmaceutically active uridine esters
US6942874B2 (en) 2001-05-25 2005-09-13 Linguagen Corp. Nucleotide compounds that block the bitter taste of oral compositions
EP1285590A1 (en) 2001-08-08 2003-02-26 Société des Produits Nestlé S.A. Lipid blends
NL1019368C2 (nl) * 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US20030114415A1 (en) * 2001-12-14 2003-06-19 Wurtman Richard J. Compositions and methods for treating and preventing memory impairment using citicoline
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
DE602004020809D1 (de) 2003-10-24 2009-06-04 Nutricia Nv Immunmodulierende Oligosaccharide
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
US9572830B2 (en) * 2004-05-13 2017-02-21 Massachusetts Institute Of Technology Uridine effects on dopamine release
CA2579851C (en) * 2004-09-15 2018-09-04 Massachusetts Institute Of Technology Use of uridine for improving cognitive and neurological functions
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
US20060252775A1 (en) 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
HUE031206T2 (en) * 2005-05-23 2017-06-28 Massachusetts Inst Technology Formulations and methods of application containing PUFA
EP1915144A4 (en) 2005-06-20 2009-08-19 Accera Inc METHOD FOR REDUCING OXIDATIVE DAMAGE AND IMPROVING MITOCHONDRIA EFFICIENCY
JP5967855B2 (ja) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
JP5697293B2 (ja) 2005-06-30 2015-04-08 サントリーホールディングス株式会社 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物
MX336435B (es) * 2005-07-08 2016-01-19 Dsm Ip Assets Bv Acidos grasos poliinsaturados para el tratamiento de demencia y condiciones relacionadas con pre-demencia.
WO2007058523A1 (en) * 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
US20070140992A1 (en) * 2005-12-21 2007-06-21 Lynn Schick Taste masking of essential oils using a hydrocolloid
DK1800675T3 (da) * 2005-12-23 2011-09-05 Nutricia Nv Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
CN104825480A (zh) 2007-06-26 2015-08-12 N·V·努特里奇亚 在简易精神状态检查值为24-26的受试者中改善记忆
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009057994A1 (en) 2007-11-02 2009-05-07 N.V. Nutricia Unit dosage for brain health
CN101951923B (zh) * 2007-12-20 2013-10-30 N.V.努特里奇亚 含核苷酸/核苷的液态产品
JP5397321B2 (ja) * 2009-06-09 2014-01-22 株式会社デンソー 駐車支援システム
US8282335B2 (en) 2009-06-12 2012-10-09 Rs Drawings, Llc Liftgate and mounting bracket system
JP5816171B2 (ja) 2009-07-24 2015-11-18 アマゼンティス エスアーＡｍａｚｅｎｔｉｓ Ｓａ 神経変性障害における脳の健康を保護するための化合物、組成物および方法
WO2012091542A1 (en) * 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
WO2013066151A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Improving recognition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109310662A (zh) * 2016-04-18 2019-02-05 N·V·努特里奇亚 用于减少生命早期应激诱导的认知下降/神经发生减少的亚油酸和α-亚麻酸

Also Published As

Publication number Publication date
BRPI0813770A2 (pt) 2014-12-30
CA2692309A1 (en) 2008-12-31
EP2170316A1 (en) 2010-04-07
JP5841723B2 (ja) 2016-01-13
NZ582329A (en) 2012-09-28
US20100331258A1 (en) 2010-12-30
JP2014074076A (ja) 2014-04-24
BRPI0813770A8 (pt) 2017-06-06
CA2692309C (en) 2016-08-16
PL2170316T3 (pl) 2014-06-30
US12233039B2 (en) 2025-02-25
BRPI0813770B1 (pt) 2018-05-08
RU2677345C2 (ru) 2019-01-16
ES2808406T3 (es) 2021-02-26
RU2014122168A (ru) 2015-12-10
EP2689782B1 (en) 2020-05-13
ES2445401T3 (es) 2014-03-03
PT2170316E (pt) 2014-01-30
EP2689782A1 (en) 2014-01-29
CN101765427A (zh) 2010-06-30
DK2170316T3 (en) 2014-02-24
US20220280466A1 (en) 2022-09-08
RU2010102237A (ru) 2011-08-10
JP5934265B2 (ja) 2016-06-15
AU2008269728A1 (en) 2008-12-31
EP2170316B1 (en) 2013-12-18
RU2529815C2 (ru) 2014-09-27
AU2008269728B2 (en) 2013-10-31
WO2009002166A1 (en) 2008-12-31
JP2010531351A (ja) 2010-09-24
US20200197345A1 (en) 2020-06-25
MX2010000224A (es) 2010-05-03
NZ599748A (en) 2013-11-29
US11395810B2 (en) 2022-07-26

Similar Documents

Publication Publication Date Title
US12233039B2 (en) Memory in subjects with mini-mental state examination of 24-26
JP6196359B2 (ja) 神経外傷を治療するための方法
AU2016202656B2 (en) Combination of components for the prevention and treatment of frailty
CN104039318B (zh) 改善认知
RU2637089C2 (ru) Способ улучшения управляющих функций
RU2705208C2 (ru) Способ для оценки и лечения или профилактики нарушенных уровней полярных липидов в плазме
US9968629B2 (en) Product and method for supporting uridine homeostasis
CN104136024A (zh) 用于改善神经心理成套测验得分的组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150812